Skip to main content
    P

    PepGen Ltd (PEPG)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.19
    -0.17 (-3.90%)

    Market Cap: $410.98M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    PepGen Ltd (PEPG) Financials: Revenue, Profit and Cash Flow

    Updated Nov 10, 2026. Financial statements from company filings, amounts in US dollars.

    PepGen reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$89.66M, operating cash flow was -$81.64M and free cash flow was -$81.90M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$19.39M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $93.61M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Cost of revenue$0$0$0$0$0$110.00K$106.00K
    Gross profit$0$0$0$0$0-$110.00K-$106.00K
    Research and development$71.04M$76.48M$68.13M$54.08M$19.00M$1.12M$620.00K
    Operating income-$93.61M-$97.74M-$84.77M-$68.30M-$27.11M-$1.88M-$1.35M
    Net income-$89.66M-$89.98M-$78.63M-$69.10M-$27.28M-$1.89M-$1.35M
    EBITDA-$90.69M-$96.41M-$84.32M-$67.70M-$27.10M-$1.77M-$1.25M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$0$1.49M$0$0$0$1.66M
    Gross profit$0$0$0-$1.06M$0$0$0-$380.00K$0$0$0-$354.00K
    Operating income-$20.38M-$18.94M-$18.94M-$19.70M-$18.65M-$23.93M-$31.32M-$24.34M-$23.17M-$30.43M-$19.80M-$20.81M
    Net income-$19.39M-$17.81M-$17.76M-$18.34M-$18.03M-$23.09M-$30.20M-$22.24M-$21.38M-$28.34M-$18.02M-$19.50M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $3.19M by $57.33M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$173.91M$150.88M$143.05M$217.44M$143.64M$10.64M$4.19M
    Current assets$150.96M$123.76M$112.68M$186.08M$139.99M$10.32M$3.77M
    Cash and equivalents$60.51M$49.42M$80.77M$181.75M$132.90M$9.78M$3.49M
    Total liabilities$26.46M$32.26M$34.63M$37.81M$10.55M$868.00K$326.00K
    Short-term debt$3.19M$3.09M$3.00M$5.55MN/AN/AN/A
    Shareholder equity$147.44M$118.62M$108.42M$179.63M-$32.08M$9.77M$3.87M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$127.78M$141.40M$156.29M$173.91M$190.06M$102.24M$127.39M$150.88M$170.23M$193.51M$207.00M$143.05M
    Total liabilities$24.71M$21.86M$22.32M$26.46M$26.92M$31.08M$35.59M$32.26M$32.78M$38.47M$28.00M$34.63M
    Cash and equivalents$21.96M$22.76M$42.15M$60.51M$142.78M$35.07M$43.63M$49.42M$42.29M$66.08M$133.85M$80.77M
    Shareholder equity$103.07M$119.53M$133.98M$147.44M$163.14M$71.16M$91.81M$118.62M$137.46M$155.04M$179.00M$108.42M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$81.64M-$82.37M-$69.00M-$59.27M-$22.60M-$1.65M-$885.00K
    Capital expenditures$264.00K$497.00K$2.60M$3.75M$500.00K$8.00K$29.00K
    Free cash flow-$81.90M-$82.87M-$71.60M-$63.02M-$23.10M-$1.66M-$914.00K
    Investing cash flow-$15.23M-$37.67M-$32.00M-$3.75M-$500.00K-$8.00K-$29.00K
    Financing cash flow$107.98M$88.75M-$189.00K$112.19M$147.66M$7.95M$2.79M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$13.18M-$15.81M-$18.43M-$15.85M-$19.26M-$23.60M-$22.93M-$19.48M-$24.01M-$16.35M-$22.53M-$19.42M
    Capital expendituresN/A$30.00K$0$1.00K$97.00K$43.00K$125.00K$228.00K$185.00K$31.00K$53.00K$184.00K
    Free cash flowN/A-$15.84M-$18.43M-$15.85M-$19.36M-$23.64M-$23.05M-$19.70M-$24.20M-$16.38M-$22.59M-$19.61M
    Last 12 quarters

    Frequently Asked Questions About PEPG

    What is PepGen's annual revenue?

    PepGen reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is PepGen profitable?

    No. PepGen reported net income of -$89.66M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does PEPG generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$81.64M minus capital expenditures of $264.00K produced free cash flow of -$81.90M.

    How much debt does PepGen have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $3.19M and cash and equivalents of $60.51M.